The landscape of wearable sensors in clinical trials has proven difficult to navigate for many, including sponsors and vendors.
Collaboration around the development of digital endpoints with a focus on data quality, validation, compliance, and clinical utility is required to extract the most from new digital technologies.
In this 20-minute presentation, VivoSense lead scientist, Kate Lyden, PhD., and Jeremy Wyatt, President of ActiGraph, discuss:
Characteristics of clinically meaningful endpoints
The data behind developing a novel digital biomarker called the Best 6 Minute Effort (B6ME) an outcome assessment that can augment the in-clinic 6 Minute Walk Test (6MWT) with real-world data collected from a wearable sensor
During this presentation, our lead scientist, Kate Lyden, PhD., and industry leaders share essential guidelines to start with the end in mind and take a comprehensive approach when validating new wearable solutions for clinical trials. Learn how best practice implementation will maximize the value of your data in the long term. Watch Now
In this presentation, Dudley Tabakin, VivoSense CEO, discusses critical details about how to drive meaningful clinical trial data. He’ll share an internal study in which real-world respiration data were analyzed from 61 patients with Spinal Muscular Atrophy (SMA). Watch Now
Escalating costs and plummeting success rates has the pharmaceutical industry reevaluating how clinical drug trials are conducted. During this webinar presentation, you’ll hear from an expert panel about bringing digital endpoints online as quickly as practically possible. Watch Now
During this presentation, our lead scientist, Kate Lyden, Ph.D, shares an example of one of the first regulated clinical trials that used a wearable sensor to monitor or measure a digital biomarker in a patient’s home setting. Watch Now
VivoSense Software and Services are Used in over 1500 Peer-Reviewed Publications.
Click on a topic below to view the related publications.